Cargando…

Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease

Objective: To summarize the situation of antineoplastic agents-induced interstitial lung diseases (ILD), provide reference for strengthening clinical management of druginduced interstitial lung diseases (DILD). Methods: We retrospectively investigated the medical records of 12 patients with antineop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiao, Gu, Yong-Li, Liu, Xu-Chao, Sun, Zeng-Xian, Sun, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493388/ https://www.ncbi.nlm.nih.gov/pubmed/37701034 http://dx.doi.org/10.3389/fphar.2023.1218480

Ejemplares similares

Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents
por: Wang, Yan, et al.
Publicado: (2023)

Development of the First Value Assessment Index System for Off-Label Use of Antineoplastic Agents in China: A Delphi Study
por: Jiang, Qian, et al.
Publicado: (2020)

Metformin Adjunct With Antineoplastic Agents for the Treatment of Lung Cancer: A Meta-Analysis of Randomized Controlled Trials and Observational Cohort Studies
por: Luo, Xiaofeng, et al.
Publicado: (2021)

Promising Antineoplastic Actions of Melatonin
por: Favero, Gaia, et al.
Publicado: (2018)

First use of antineoplastic agents in women with breast cancer in the state of Rio de Janeiro, Brazil
por: dos Santos, Ranailla Lima Bandeira, et al.
Publicado: (2023)

Potentially Hazardous Drug-Drug Interactions Associated With Oral Antineoplastic Agents Prescribed in Chinese Tertiary Care Teaching Hospital Settings: A Multicenter Cross-Sectional Study
por: Wang, Haitao, et al.
Publicado: (2022)

Case Report: Afatinib-Induced Interstitial Pneumonia: Experiences and Lessons From Two Patients
por: Liu, Xiao, et al.
Publicado: (2021)

Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases
por: Chen, Xianqiu, et al.
Publicado: (2021)

A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease
por: Gu, Yong-Li, et al.
Publicado: (2022)

Potential of resveratrol in the treatment of interstitial lung disease
por: Huo, Rongxiu, et al.
Publicado: (2023)

Antineoplastic and Immunosuppressive Agents—Part 1
por: Lajtha, L. G.
Publicado: (1975)

Extravasation of Antineoplastic Agents: Prevention and Treatments
por: Boschi, Rita, et al.
Publicado: (2012)

Antineoplastic Agents Targeting Sphingolipid Pathways
por: Kroll, Alexander, et al.
Publicado: (2020)

Advances in thiosemicarbazone metal complexes as anti-lung cancer agents
por: Bai, Xian-Guang, et al.
Publicado: (2022)

Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis
por: Liu, Xiao-Yuan, et al.
Publicado: (2022)

Disturbing effect of cepharanthine on valve interstitial cells calcification via regulating glycolytic metabolism pathways
por: Xie, Fei, et al.
Publicado: (2022)

Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world
por: Kaku, Sawako, et al.
Publicado: (2022)

Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study
por: Tran, Thien B., et al.
Publicado: (2018)

The Off-Label Use of Antineoplastics in Oncology Is Limited But Has Notable Scientific Support in a University Hospital Setting
por: Herrero Fernandez, Marta, et al.
Publicado: (2019)

Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline
por: Nagy, Alexandra, et al.
Publicado: (2021)

Correction to: Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world
por: Kaku, Sawako, et al.
Publicado: (2022)

Gold(III)–pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents**
por: Nardon, Chiara, et al.
Publicado: (2015)

Oral Antineoplastic Agents: Assessing the Delay in Care
por: Anders, Brandi, et al.
Publicado: (2015)

Computer-aided predictions of potential antineoplastic agents
por: Zakharov, Alexey, et al.
Publicado: (2008)

Design and Synthesis of Organic Molecules as Antineoplastic Agents
por: Boga, Carla, et al.
Publicado: (2020)

An appraisal of the current status of inhibition of glucose transporters as an emerging antineoplastic approach: Promising potential of new pan-GLUT inhibitors
por: Temre, Mithlesh Kumar, et al.
Publicado: (2022)

Antineoplastic prescription among patients with colorectal cancer in eight major cities of China, 2015–2019: an observational retrospective database analysis
por: Yao, Difei, et al.
Publicado: (2021)

Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbits
por: Kohno, Emiko, et al.
Publicado: (2009)

Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis
por: Liu, Jiarong, et al.
Publicado: (2022)

A Risk-Factor Model for Antineoplastic Drug-Induced Serious Adverse Events in Cancer Inpatients: A Retrospective Study Based on the Global Trigger Tool and Machine Learning
por: Zhang, Ni, et al.
Publicado: (2022)

NPV-BSK805, an Antineoplastic Jak2 Inhibitor Effective in Myeloproliferative Disorders, Causes Adiposity in Mice by Interfering With the Action of Leptin
por: Haissaguerre, Magalie, et al.
Publicado: (2018)

Rituximab for the treatment of connective tissue disease–associated interstitial lung disease: A systematic review and meta-analysis
por: Xu, Linrui, et al.
Publicado: (2022)

CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway
por: Sun, Meng-Yao, et al.
Publicado: (2019)

Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis
por: Wei, Guoxu, et al.
Publicado: (2021)

Alpha5 Nicotinic Acetylcholine Receptor Contributes to Nicotine-Induced Lung Cancer Development and Progression
por: Sun, Hai-Ji, et al.
Publicado: (2017)

Editorial: The developments of metal-based agents against lung cancer
por: Gou, Yi, et al.
Publicado: (2022)

Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways
por: Sun, Chao-Yue, et al.
Publicado: (2018)

Early effects of the antineoplastic agent salinomycin on mitochondrial function
por: Managò, A, et al.
Publicado: (2015)

Editor’s choice 2019: Oxidative stress and antineoplastic agents
por: Ghallab, Ahmed
Publicado: (2020)

1,2,3-Triazole-Containing Compounds as Anti–Lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure–Activity Relationship
por: Liang, Ting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hs9smqhjspk6l41m983vokb2g7